Claudia Fortuny | Antoni Noguera
Transferring HIV Infected Adolescents to an Adult Outpatient Clinic. What should we take care of?.
José A. Muñoz-Moreno | Daniel Podzamczer
Management of Neurocognitive Impairment in HIV Patients: Recommendations from the Recently Published Spanish Guidlines (GESIDA 2013).
J. Allen McCutchan
Obesity, Diabetes, and HIV: Intersecting Epidemic Contributing to NeuroAIDS?.
Controversies: Screening and Management of HAND.
Alcohol Use: Impact on HAND and Other Health Issues in HIV-Infected Patients, Screening and Management.
Effect of Second Generation Antipsychotics on Metabolic and Vascular Risk Factors in HIV-infected Adults on Long Term Antiretroviral Therapy.
Juan V. Esplugues
A differential bioenergetic effect in human glia and neurons under treatment with the antiretroviral drug Efavirenz.
Comparative Neuropsychiatric Profile of Dolutegravir and Efavirenz after 48w in treatment naïve patients: Data from ING114467 SINGLE study.
Switch from Efavirenz for CNS toxicity-UK experience.
Neuropsychological performance in acute HIV: determinants of baseline performance and effects of immediate antiretroviral therapy